FI20105970A - Improved dietary compensation for the treatment and prevention of cancer - Google Patents

Improved dietary compensation for the treatment and prevention of cancer Download PDF

Info

Publication number
FI20105970A
FI20105970A FI20105970A FI20105970A FI20105970A FI 20105970 A FI20105970 A FI 20105970A FI 20105970 A FI20105970 A FI 20105970A FI 20105970 A FI20105970 A FI 20105970A FI 20105970 A FI20105970 A FI 20105970A
Authority
FI
Finland
Prior art keywords
cancer
compensation
prevention
treatment
improved dietary
Prior art date
Application number
FI20105970A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI123756B (en
FI20105970A0 (en
Inventor
Thomas Tallberg
Original Assignee
Neurofood Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurofood Ab Oy filed Critical Neurofood Ab Oy
Priority to FI20105970A priority Critical patent/FI123756B/en
Publication of FI20105970A0 publication Critical patent/FI20105970A0/en
Priority to PCT/FI2011/050784 priority patent/WO2012038590A1/en
Publication of FI20105970A publication Critical patent/FI20105970A/en
Application granted granted Critical
Publication of FI123756B publication Critical patent/FI123756B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20105970A 2010-09-21 2010-09-21 Improved nutritional supplementation for the treatment and prevention of cancer FI123756B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20105970A FI123756B (en) 2010-09-21 2010-09-21 Improved nutritional supplementation for the treatment and prevention of cancer
PCT/FI2011/050784 WO2012038590A1 (en) 2010-09-21 2011-09-13 Improved dietary substitution for treating or preventing cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20105970 2010-09-21
FI20105970A FI123756B (en) 2010-09-21 2010-09-21 Improved nutritional supplementation for the treatment and prevention of cancer

Publications (3)

Publication Number Publication Date
FI20105970A0 FI20105970A0 (en) 2010-09-21
FI20105970A true FI20105970A (en) 2012-03-22
FI123756B FI123756B (en) 2013-10-31

Family

ID=42829701

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105970A FI123756B (en) 2010-09-21 2010-09-21 Improved nutritional supplementation for the treatment and prevention of cancer

Country Status (2)

Country Link
FI (1) FI123756B (en)
WO (1) WO2012038590A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2529270B (en) 2015-01-02 2016-07-27 Becton Dickinson Co Safety intravenous catheter with friction-based retention and disabling feature
CN109172552A (en) * 2018-07-18 2019-01-11 浙江格蕾斯生物科技有限公司 Prostate cancer plant prevention drug and preparation method
JP7311086B2 (en) * 2019-08-21 2023-07-19 ブレイン ケミストリー ラブズ Compositions containing metals and L-serine, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7350500A (en) * 1999-08-31 2001-03-26 Brian C. Giles Method and formula for tumor remission and suppression of cancer
ES2342461T3 (en) * 2003-10-17 2010-07-07 Oy Neurofood Ab NON-RADIOACTIVE STRONTIUM AGENT TO TREAT CANCER.
FI122450B (en) * 2007-12-28 2012-01-31 Neurofood Ab Oy A composition for the treatment of sterile inflammation

Also Published As

Publication number Publication date
FI123756B (en) 2013-10-31
FI20105970A0 (en) 2010-09-21
WO2012038590A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
IL225471B (en) Compositions for the prevention and treatment of cancer
PL2532365T3 (en) Pharmaceutical composition for treatment and/or prevention of cancer
EP2532743A4 (en) Pharmaceutical composition for treatment and/or prevention of cancer
EP2740795A4 (en) Cancer treatment and/or prevention drug composition
EP2740798A4 (en) Cancer treatment and/or prevention drug composition
PL2740793T3 (en) Drug composition for cancer treatment and/or prevention
PL2532366T3 (en) Pharmaceutical composition for treating and/or preventing cancer
EP2532364A4 (en) Pharmaceutical composition for treating and/or preventing cancer
IL251083A0 (en) Compounds and compositions for the treatment of cancer
SG10201508495VA (en) Combination treatment of cancer
EP2558085A4 (en) Compositions and methods for the prevention and treatment of cancer
PL2605764T3 (en) Compositions for the treatment of cancer
ZA201300762B (en) Novel combination therapy for the treatment of cancer
HK1204605A1 (en) Functionalized thieno-indole derivatives for the treatment of cancer
EP2635273A4 (en) Isoflavonoid compositions and methods for the treatment of cancer
EP2661434A4 (en) Novel ureas for the treatment and prevention of cancer
FI20115862A (en) Lipid composition for the prevention or treatment of skin problems
FI20105970A (en) Improved dietary compensation for the treatment and prevention of cancer
EP2547368A4 (en) Methods and compositions for the treatment of cancer
IL223219A0 (en) Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
IL221238A0 (en) Pharmaceutical compositions and methods for the treatment and prevention of cancer
HK1202118A1 (en) Piperazinyl derivatives for the treatment of cancer
GB201017356D0 (en) Combination treatment of cancer
GB201017354D0 (en) Treatment of cancer
AU2010904107A0 (en) Treatment of cancer

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 123756

Country of ref document: FI

Kind code of ref document: B

MM Patent lapsed